BlockchAIn Digital Infrastructure Expected to Trade on NYSE American Under Ticker Symbol “AIB” Following Completion of Proposed Business CombinationSCOTTSDALE, AZ, March 06, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), would like to remind its stockholders that it will hold a special meeting of its stockholders (the “Special Meeting”) on Friday, March 13, 2026, at which stockholders will be asked to consider and vote on the approval of the C ...

Correction has been made to the consolidated interim income statement: comparative periods for 25H2 and 24H2 have been added. --- Sales Revenues and Profitability In 2025, the Baltic energy sector experienced significant developments and challenges, both of which had a major impact on energy security and prices. The energy market, which was previously stable and predictable, has undergone rapid changes in recent years, with prices becoming increasingly volatile. In 2025 sales revenue totalled EUR 1,646.9 mi ...

WEST HOLLYWOOD, Calif. and MODI’IN, Israel, March 06, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”) announced today that C.M. Composite Materials Ltd. (“C.M.”), together with its wholly owned subsidiary FBM Composite Materials Ltd., has entered into a Memorandum of Understanding (MOU) with a large industrial manufacturing group headquartered in India to explore the formation of a joint venture manufacturing platform for advanced aerospace and defense compo ...

INDIANAPOLIS, March 06, 2026 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the first fiscal quarter ended January 31, 2026. Hurco recorded a net loss of $3,468,000, or $0.54 loss per diluted share, for the first quarter of fiscal year 2026, compared to a net loss of $4,320,000, or $0.67 loss per diluted share, for the corresponding period in fiscal year 2025. Sales and service fees for the first quarter of fiscal year 2026 were $42,868,000, a decrease of $3,546,000, or ...

Not for Distribution to United States News Wire Services or for Dissemination in the United StatesMONTREAL, March 06, 2026 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ) (“BRW” or the “Corporation”) is pleased to announce that as a result of strong investor demand, it has increased the maximum gross proceeds of its previously announced non-brokered private placement from $4,000,000 to $5,500,000 (the “Offering”). The upsized Offering now consists of the sale of up t ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C mutationRezatapopt granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of TP53 Y220C positive ovarian cancerNew England Journal of Medicine published first-in-human rezatapopt data showing selective reactivation of mutant p53 in advanced solid tumorsRezatapopt New Drug Application submis ...

Management and Board Have Collectively Committed Up to $42.75 Million to Prenetics Stock Backed by $164 Million in Total Adjusted Liquidity, Zero Debt IM8 Targeting $180M to $200M in 2026 Full Year Revenue, and a Clear Path to Adjusted EBITDA Profitability by Q4 2027 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that its Bo ...

EMERYVILLE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- NMI Holdings, Inc., (NASDAQ:NMIH) announced today that Adam Pollitzer, the company’s President and Chief Executive Officer, and Aurora Swithenbank, Executive Vice President and Chief Financial Officer, will be participating at the RBC Global Financial Institutions Conference on March 11th in New York City. A presentation that may be referenced during the conference will be available on the company’s website at https://ir.nationalmi.com/investor-relation ...

GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2025 fiscal year ended December 31, 2025. Key Highlights: Regulatory Progress: Achieved positive clinical study results from the AD04-103 pharmacokinetics (PK) study su ...

CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit q ...